- Grifols Supports AlphaDetect to Accelerate Detection of Alpha-1 — The sponsorship will help expand proven strategies to consistently detect a genetic, irreversible, and progressive condition in patients with liver and/or lung disease.
- DURHAM, N.C., June 5, 2026 /PRNewswire/ -- AlphaDetect, the nonprofit detection organization powered and funded by the...
Operational Impact: This geographic footprint move can alter CDMO vendor risk for comparable outsourcing scopes—confirm whether active partners still meet timeline, compliance, and site-level assumptions. Source: PR Newswire pharma category RSS
- Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode® for Neurogenic Bladder in Spinal Cord Injury — Needle-Delivered Electrode Enables Outpatient Placement and At-Home Stimulation for Spinal Cord Injury Patients With Neurogenic Bladder CLEVELAND and HOUSTON, June 5, 2026 /PRNewswire/ -- Neuronoff, Inc., a clinical-stage neuromodulation company, today announced the first patient implant...
- Neuronoff Implants First Patient in DOD-Funded Trial of Injectrode® for Neurogenic Bladder in Spinal Cord Injury — outsourcing teams should verify scope against the primary source.
Operational Impact: This capacity & infrastructure move can alter CDMO vendor risk for comparable outsourcing scopes—confirm whether active partners still meet timeline, compliance, and site-level assumptions. Source: PR Newswire pharma category RSS
- WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility — SINGAPORE, June 4, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub (Hub).
- Once operational,...
Operational Impact: WuXi Biologics's capacity & infrastructure signal may change which CDMO partners are credible for overlapping programs—validate capacity claims, audit history, and geographic coverage before adjusting shortlists. Source: PR Newswire pharma category RSS
How this was written: Transparency methodology
> Some claims require additional source verification.